Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Remote Blood-Draw Dried-Spot Device Market Size And Revenue Outlook Through 2030
The remote blood-draw dried-spot device market size has observed substantial growth in recent years. It is projected to expand from $0.92 billion in 2025 to $1.05 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.5%. The expansion witnessed during the historic period can be attributed to several factors, including the increase in remote diagnostics, the requirement for enhanced patient convenience, the broadening of lab testing services, the implementation of newborn screening programs, and the general advancement of telemedicine.
The market for remote blood-draw dried-spot devices is projected to experience significant expansion in the upcoming years. It is expected to grow to $1.73 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.2%. This growth during the forecast period can be attributed to factors such as the expansion of home healthcare, increased monitoring of chronic diseases, the growth of digital pathology, optimized logistics, and advancements in population health management. Prominent trends anticipated in this period include the prevalence of at-home blood sample collection, the rise of mail-in diagnostic testing, the development of minimally invasive sampling devices, the adoption of microfluidic blood collection methods, and the shift towards decentralized diagnostic testing.
Get A Free Sample Report With In-Depth Market Insights:
Remote Blood-Draw Dried-Spot Device Market Growth Drivers: What’s Behind The Acceleration?
The heightened focus on personalized medicine is projected to stimulate the expansion of the remote blood-draw dried-spot device market in the future. Personalized medicine involves adapting medical treatments and preventative approaches to an individual’s unique genetic, molecular, and clinical profiles to achieve the best possible results. The uptake of personalized medicine is rising because genomic advancements facilitate accurate detection of genetic differences influencing disease susceptibility and therapy effectiveness, leading to more precise and impactful treatments. Remote blood-draw dried-spot devices support personalized medicine by offering an easy, home-based method for collecting small blood samples, which permits regular tracking of biomarkers and genetic data to inform customized treatment and therapeutic choices. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA endorsed 16 new personalized treatments for rare disease patients, an increase from six in 2022. Additionally, the newly sanctioned personalized treatments for 2023 comprised seven cancer drugs and three for other diseases and conditions. Consequently, the growing focus on personalized medicine is fueling the expansion of the remote blood-draw dried-spot device market.
Remote Blood-Draw Dried-Spot Device Market Segment Analysis And Revenue Potential
The remote blood-draw dried-spot device market covered in this report is segmented –
1) By Product Type: Filter Paper Devices, Microfluidic Devices, Other Product Types
2) By Sample Type: Whole Blood, Plasma, Serum, Other Sample Types
3) By Distribution Channel: Direct Sales, Online Retail, Pharmacies, Other Distribution Channels
4) By Application: Disease Diagnosis, Therapeutic Drug Monitoring, Newborn Screening, Forensic Testing, Other Applications
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Home Care Settings, Other End-Users
Subsegments:
1) By Filter Paper Devices: Whole Blood Collection Cards, Plasma Separation Cards
2) By Microfluidic Devices: Integrated Microchannel Systems, Capillary-Driven Microfluidic Chips
3) By Other Product Types: Volumetric Absorptive Micro sampling Devices, Capillary Blood Collection Tubes
Remote Blood-Draw Dried-Spot Device Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies in the remote blood-draw dried-spot device market are concentrating on developing advanced methods, such as decentralized sampling, to facilitate at-home or remote blood collection, thereby improving patient convenience and enhancing clinical trial efficiency. Decentralized sampling refers to the method of acquiring biological specimens at locations convenient for the patient rather than at centralized laboratories or clinics, which allows for broader access, faster collection, and more flexible participation in healthcare or research studies. For instance, in March 2025, Tasso Inc., a US-based healthcare technology company, unveiled a next-generation technology for dried blood spot (DBS) sample collection, specifically designed for clinical trials and sports anti-doping testing. This technology provides a virtually painless, convenient, and precise approach for blood sampling, making it ideal for clinical trials and sports anti-doping programs. It delivers accurate volumetric blood samples utilizing a patient-friendly device, which improves compliance and enables remote collection. By simplifying the sampling process, reducing participation barriers, and generating high-quality quantitative data, it accelerates drug development and supports decentralized testing models.
Remote Blood-Draw Dried-Spot Device Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the remote blood-draw dried-spot device market are Neoteryx Inc., DBS System SA, Tasso Inc., Capitainer AB, Spot On Sciences Inc., HemaXis S.A., Drawbridge Health Inc., RDA Spot Inc., YourBio Health Inc., Lipomic Healthcare Inc., Trajan Scientific and Medical Pty Ltd., Salimetrics LLC, Eastern Business Forms Inc., PanoHealth Inc., RedDrop Dx Inc., Nanowear Inc., Bioanalytical Systems Inc., Phenomenex Inc., Greiner Bio-One International GmbH, Whatman (Cytiva)
View The Full Remote Blood-Draw Dried-Spot Device Market Report:
Remote Blood-Draw Dried-Spot Device Market Geographic Distribution And Regional Opportunities
North America was the largest region in the remote blood-draw dried-spot device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remote blood-draw dried-spot device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
